Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • 312 Female sex independently p...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
312 Female sex independently predicts adjuvant immunotherapeutic benefit from CTLA4 immune checkpoint inhibition

312 Female sex independently predicts adjuvant immunotherapeutic benefit from CTLA4 immune checkpoint inhibition

Bibliographic Details
Main Authors: Gary Cohen, Omid Hamid, Lawrence Flaherty, Henry Koon, Jeffrey Sosman, David Minor, Zeynep Eroglu, John Kirkwood, F Stephen Hodi, Donald Lawrence, Ni Kang, Sandra Lee, Laura Hutchins, Harriett Kluger, Kari Kendra, Carrie Lee, Mark Albertini, Teresa Petrella, Howard Striecher, Vernon Sondak
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis
    by: F Stephen Hodi, et al.
    Published: (2021-05-01)
  • Diverse mechanisms regulate the surface expression of immunotherapeutic target CTLA-4
    by: Helga eSchneider, et al.
    Published: (2014-12-01)
  • A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma
    by: Ying Mei, et al.
    Published: (2021-03-01)
  • Design and Development of Peptidomimetic Ligands for Targeting Radiopharmaceuticals, Imaging Probes, and Immunotherapeutics in Oncologic Disease
    by: Doligalski, Michael Lawrence
    Published: (2016)
  • Immunotherapeutic Challenges for Pediatric Cancers
    by: Brian Hutzen, et al.
    Published: (2019-12-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...